Cargando…

PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas

There is an urgent clinical need for new therapeutic regimens for the effective treatment of advanced sarcomas. Accumulating evidence suggests that programmed death receptor-1/programmed death protein ligand-1 (PD-1/L1) inhibitors have synergistic effects with chemotherapy and have been approved for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhichao, Yao, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441887/
https://www.ncbi.nlm.nih.gov/pubmed/36072581
http://dx.doi.org/10.3389/fimmu.2022.898255